Prestin Degradome Foundation Atlas

It belongs to the SLC26 family of anion transport-related proteins and functions as the molecular motor underlying the electromotility of outer hair cells (with the exception of very high frequencies).</p><p dir="ltr">Prestin is essential for the amplification and fine tuning of sound-induced mechanical vibrations within the cochlea. Changes in Prestin structure or function can therefore affect the ability of outer hair cells to amplify acoustic signals and contribute to normal auditory sensitivity and frequency selectivity.</p><p dir="ltr">The <b>A216T</b> substitution is associated with <b>sensorineural hearing loss</b>, making it particularly relevant to investigations of Prestin sequence variation and auditory dysfunction.

The <b>A296V</b> substitution represents an additional Prestin variant included in this atlas, providing an opportunity to compare its theoretical peptide landscape with that of the reference protein.</p><p dir="ltr">Because sequence variation can alter peptide composition, molecular mass, charge, physicochemical properties, and potentially proteolytic susceptibility, variant-specific degradome analysis can provide a computational framework for identifying peptides that distinguish wild-type and altered Prestin sequences.</p><h3 dir="ltr">Key Features of the Proteomics Dataset</h3><p dir="ltr">The <b>Prestin Degradome Foundation Atlas</b> provides a systematic computational representation of the theoretical peptide space associated with the reference and variant Prestin sequences.</p><p dir="ltr">The atlas includes:</p><ul><li><b>Wild-type Prestin (SLC26A5)</b> theoretical peptide landscape</li><li><b>A216T variant</b> associated with sensorineural hearing loss</li><li><b>A296V variant</b> included as a Prestin sequence variant</li><li>Predicted enzymatic and chemical cleavage sites</li><li>Potential contiguous peptide fragments generated through proteolytic cleavage</li><li>Variant-specific peptide sequences where applicable</li><li>Fragment-level physicochemical and biochemical characteristics</li></ul><p dir="ltr"><b>Mass Spectrometry and Peptide Metrics:</b></p><ul><li>Molecular weight</li><li>Mass-to-charge ratio (m/z)</li><li>Net charge</li><li>Isoelectric point (pI)</li></ul><p dir="ltr"><b>Biochemical and Biophysical Features:</b></p><ul><li>Hydrophobicity</li><li>Boman index</li><li>Instability index</li><li>Aliphatic index</li></ul><p dir="ltr">These calculated parameters provide a multidimensional computational reference for evaluating Prestin-derived peptides and identifying sequence-dependent differences that may be relevant to proteomic detection and biomarker development.</p><h3 dir="ltr">Applications in Biomarker Discovery and Biomedical Research</h3><p dir="ltr">The dataset can support a range of research applications, including:</p><ul><li><b>Targeted Proteomics:</b> Identification and prioritization of Prestin-derived peptides for targeted mass-spectrometry assays.</li><li><b>Variant-Specific Proteomics:</b> Investigation of peptide differences between wild-type Prestin and the A216T and A296V variants.</li><li><b>Biomarker Discovery:</b> Exploration of Prestin-derived peptides as candidate molecular indicators of auditory-system biology and protein variation.</li><li><b>Hearing Loss Research:</b> Supporting computational investigation of the A216T variant associated with sensorineural hearing loss.</li><li><b>Auditory Proteomics:</b> Characterization of Prestin-derived peptides relevant to cochlear and outer hair-cell biology.</li><li><b>Discovery Proteomics:</b> Generation of candidate peptide lists for untargeted proteomic investigations.</li><li><b>Degradomics:</b> Investigation of Prestin proteolytic processing and turnover through a protein-specific degradome framework.</li><li><b>Membrane Protein Research:</b> Providing a computational resource for studying the peptide landscape of a specialized integral membrane protein.</li><li><b>Variant Characterization:</b> Comparing theoretical peptide properties between reference and variant Prestin sequences.</li><li><b>Clinical Proteomics:</b> Supporting the development of candidate peptides for investigating molecular signatures associated with hearing disorders.</li><li><b>Computational Biology:</b> Enabling sequence-based degradome profiling, variant comparison, peptide prioritization, and comparative analysis.</li><li><b>Assay Development:</b> Supporting the selection of candidate Prestin peptides for future experimental validation.</li></ul><h3 dir="ltr">Variant-Specific Analysis</h3><p dir="ltr">A key feature of Version 1 is the inclusion of two Prestin sequence variants:</p><p dir="ltr"><b>A216T — Alanine-to-Threonine substitution</b></p><p dir="ltr">The A216T variant is associated with <b>sensorineural hearing loss</b> and is included to enable computational assessment of how this amino-acid substitution alters the theoretical Prestin degradome.

Variant-specific changes may affect peptide sequence, molecular mass, charge, hydrophobicity, and other calculated properties, providing candidate features for targeted proteomic investigation.</p><p dir="ltr"><b>A296V — Alanine-to-Valine substitution</b></p><p dir="ltr">The A296V variant is included as a second Prestin sequence variant for comparative degradome analysis. Theoretical peptide differences introduced by this substitution can be evaluated alongside the wild-type sequence to identify candidate variant-discriminating peptides and assess changes in calculated peptide characteristics.</p><p dir="ltr">Together, these variants provide a computational framework for exploring how individual amino-acid substitutions may influence the predicted peptide landscape of Prestin.</p><h3 dir="ltr">Data Inclusion and Reproducibility</h3><p dir="ltr">Version 1 includes theoretical degradome representations for the <b>wild-type human Prestin sequence</b>, the <b>A216T variant</b>, and the <b>A296V variant</b>.

For each sequence, potential contiguous peptide fragments and their calculated physicochemical properties are provided.</p><p dir="ltr">The dataset represents a <b>theoretical fragment space rather than a catalogue of experimentally confirmed peptides</b>. The presence of a predicted peptide does not establish that the fragment is generated <i>in vivo</i>, remains stable in a biological sample, or is detectable by a particular mass-spectrometric platform.</p><p dir="ltr">Similarly, inclusion of a sequence variant in this atlas does not by itself establish a causal relationship between that variant and a particular phenotype beyond the biological annotation provided for the A216T variant.

Experimental proteomics, functional studies, and mass-spectrometry analyses are required to determine the biological generation, abundance, stability, detectability, and functional relevance of individual Prestin-derived peptides.</p><p dir="ltr">Future releases of the Prestin Degradome Foundation Atlas may incorporate additional SLC26A5 variants, post-translational modifications, experimentally validated cleavage products, tissue-specific degradome profiles, and complementary experimental proteomics data.

These extensions will progressively bridge the theoretical Prestin peptide landscape with experimentally informed models of protein turnover, variant-specific peptide signatures, cochlear biology, and hearing-loss research.</p>